{"id":"W3086667064","doi":"10.25251/skin.4.supp.67","title":"Duration of Response and Progression-Free Survival with Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients with Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind","year":2020,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"","keywords":"Oncology; Internal medicine; Medicine; Progression-free survival; Disease; Duration (music); Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002385263,0.0008917518,0.001852746,0.0004472858,0.0002751652,0.0006450935,0.000703959,0.001282403,0.003848704],"category_scores_gemma":[0.002102454,0.0005003778,0.001955217,0.0003800057,0.0008507939,0.001139112,0.0003888807,0.002658082,0.0004372569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007067561,"about_ca_system_score_gemma":0.0008685249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011786,"about_ca_topic_score_gemma":0.00253124,"domain_scores_codex":[0.998909,0.0006545599,0.00006805999,0.0001496459,0.00007613631,0.0001425798],"domain_scores_gemma":[0.9982657,0.0006457059,0.0004095122,0.0001483415,0.00006675303,0.000464069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9705468,0.004856511,0.001781209,0.0003340729,0.001007806,0.00001680567,0.00005195026,0.0004735824,0.002578759,0.00004030505,0.0004268651,0.01788525],"study_design_scores_gemma":[0.6243225,0.3420021,0.02719882,0.00007981869,0.002360317,0.00006514948,0.00007028502,0.001127874,0.001685367,0.0001880196,0.0008578512,0.00004185219],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942047,0.003598333,0.0001781673,0.0001860021,0.0001255244,0.0003102186,0.0004297946,0.00002675273,0.0009404904],"genre_scores_gemma":[0.9955188,0.001598281,0.0003258932,0.0002629752,0.0001936993,0.0004947706,0.0004842553,0.00001025058,0.001111094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003848704,"threshold_uncertainty_score":0.0128752,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01571963843424404,"score_gpt":0.2695627125944479,"score_spread":0.2538430741602039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}